Catalyst Wire Dossier Catalyst Wire Dossier

4-Hydroxytamoxifen Gel

4-hydroxytamoxifen gel
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 4-Hydroxytamoxifen Gel, covering 2012-05-30 to 2021-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue [Phase 3]

See pricing